Literature DB >> 17944748

The role of TNF-alpha in Trichuris muris infection II: global enhancement of ongoing Th1 or Th2 responses.

K S Hayes1, A J Bancroft, R K Grencis.   

Abstract

Host resistance to Trichuris muris is driven by Th2 responses. However, TNF-alpha has also been shown to play a role in protection. As TNF-alpha has a variety of actions, the exact role of TNF-alpha in immunity to T. muris is yet to be established. Here we demonstrate that although blocking TNF-alpha has been shown to abrogate resistance, rTNF-alpha treatment does not promote resistance. Further, we show that TNF-alpha functions to enhance the ongoing immune response. AKR animals that typically respond to infection with a polarized Th1 response produce greater levels of Th1 cytokines when treated with TNF-alpha and BALB/c animals that normally respond with a polarized Th2 response produce higher levels of Th2 cytokines. Crucially, blocking TNF-alpha in the strong Th2 responder strain BALB/c does not prevent expulsion of T. muris, thus supporting its role as a biological enhancer. TNF-alpha does increase transcription of both IFN-gamma and IL-13 in vitro but can also act synergistically with IL-13 in vitro to promote production of RELMbeta, which has also been shown to play a role in resistance to T. muris. Thus, this data demonstrates that TNF-alpha acts to enhance an ongoing immune response but is not necessary for a strong protective Th2 response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944748     DOI: 10.1111/j.1365-3024.2007.00980.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  12 in total

1.  Transmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infection.

Authors:  M X Ierna; H E Scales; C Mueller; C E Lawrence
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 2.  Helminth infection in populations undergoing epidemiological transition: a friend or foe?

Authors:  Aprilianto Eddy Wiria; Yenny Djuardi; Taniawati Supali; Erliyani Sartono; Maria Yazdanbakhsh
Journal:  Semin Immunopathol       Date:  2012-11-06       Impact factor: 9.623

3.  Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection.

Authors:  Sumaira Z Hasnain; Huaqing Wang; Jean-Eric Ghia; Nihal Haq; Yikang Deng; Anna Velcich; Richard K Grencis; David J Thornton; Waliul I Khan
Journal:  Gastroenterology       Date:  2010-02-04       Impact factor: 22.682

Review 4.  Trichuris muris: a model of gastrointestinal parasite infection.

Authors:  Joanna E Klementowicz; Mark A Travis; Richard K Grencis
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

5.  Changes in the mucosal barrier during acute and chronic Trichuris muris infection.

Authors:  S Z Hasnain; D J Thornton; R K Grencis
Journal:  Parasite Immunol       Date:  2011-01       Impact factor: 2.280

6.  Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice.

Authors:  Victoria Jeisy-Scott; William G Davis; Jenish R Patel; John Bradford Bowzard; Wun-Ju Shieh; Sherif R Zaki; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

Review 7.  Parasites-allergy paradox: Disease mediators or therapeutic modulators.

Authors:  Mohammed A Afifi; Asif A Jiman-Fatani; Sherif El Saadany; Mahmoud A Fouad
Journal:  J Microsc Ultrastruct       Date:  2015-03-17

8.  Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier.

Authors:  Sumaira Z Hasnain; Michael A McGuckin; Richard K Grencis; David J Thornton
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11

Review 9.  Trichuris muris research revisited: a journey through time.

Authors:  Rebecca J M Hurst; Kathryn J Else
Journal:  Parasitology       Date:  2013-09       Impact factor: 3.234

10.  Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization.

Authors:  M B Assas; S E Levison; M Little; H England; L Battrick; J Bagnall; J T McLaughlin; P Paszek; K J Else; J L Pennock
Journal:  Clin Exp Immunol       Date:  2016-11-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.